TickerFacts.

Nektar Therapeutics (NKTR): Gross Profit

Revenue minus cost of revenue for the same annual period and currency, computed by TickerFacts from the filed figures. The issuer may report gross profit or margin on a different basis.

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

$67.74M
Year ended 2024-12-31
-4.2%
3-year compound annual growth
-6.2%
5-year compound annual growth
-8.9%
10-year compound annual growth
$277.16M2009-12-31: $40.98M2010-12-31: $133.37M2011-12-31: $49.59M2012-12-31: $50.76M2013-12-31: $110.41M2014-12-31: $172.17M2015-12-31: $196.68M2016-12-31: $135.22M2017-12-31: $277.16M2019-12-31: $93.24M2020-12-31: $133.44M2021-12-31: $77.01M2022-12-31: $70.42M2023-12-31: $56.35M2024-12-31: $67.74M$67.74M
2009-12-31 Gross Profit (USD) 2024-12-31
Period endedGross ProfitChange YoYSource filing
2024-12-31$67.74M+20.2%2026-03-13, From 2024-01-01
2023-12-31$56.35M-20.0%2025-03-14, From 2023-01-01
2022-12-31$70.42M-8.6%2024-03-05, From 2022-01-01
2021-12-31$77.01M-42.3%2024-03-05, From 2021-01-01
2020-12-31$133.44M+43.1%2023-02-28, From 2020-01-01
2019-12-31$93.24Mn/a2022-03-01, From 2019-01-01
No annual figure between 2017-12-31 and 2019-12-31.
2017-12-31$277.16M+105.0%2020-02-28, From 2017-01-01
2016-12-31$135.22M-31.2%2019-03-01, From 2016-01-01
2015-12-31$196.68M+14.2%2018-03-01, From 2015-01-01
2014-12-31$172.17M+55.9%2017-03-01, From 2014-01-01
2013-12-31$110.41M+117.5%2016-02-29, From 2013-01-01
2012-12-31$50.76M+2.4%2015-02-26, From 2012-01-01
2011-12-31$49.59M-62.8%2014-02-27, From 2011-01-01
2010-12-31$133.37M+225.4%2013-03-01, From 2010-01-01
2009-12-31$40.98Mn/a2012-02-29, From 2009-01-01